| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.36 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |